Hot Products
Hot products from BioCrick which is a professional high-purity natural products manufacturer are well known to scientists around the world because of their high purity and stability. Each product is a chemical compound or substance produced by a living organism—that is, found in nature. In the broadest sense, natural products include any substance produced by life.Natural products remain the best sources of drugs and drug leads, and this remains true today despite the fact that many pharmaceutical companies have deemphasized natural products research in favor of HTP screening of combinatorial libraries during the past 2 decades. From 1940s to date, 131 (74.8%) out of 175 small molecule anticancer drugs are natural product-based/inspired, with 85 (48.6%) being either natural products or derived therefrom. From 1981 to date, 79 (80%) out of 99 small molecule anticancer drugs are natural product-based/inspired, with 53 (53%) being either natural products or derived therefrom. Among the 20 approved small molecule New Chemical Entities (NCEs) in 2010, a half of them are natural products.
Hot products from the professional high-purity natural products manufacturer
Cat.No. | Product Name |
---|---|
BCN4085 | Magnolignan C |
Magnolignan C is a natural product from Magnolia officinalis. | |
BCN4516 | Maoecrystal B |
Standard reference | |
BCN3283 | Maoyecrystal E |
Maoyecrystal E is a natural product from Isodon japonicus. | |
BCN3944 | Maoyerabdosin |
Standard reference | |
BCN4564 | Marsdenoside F |
Marsdenoside F is a natural product from Marsdenia tenacissima. | |
BCN4511 | Massoniresinol |
Standard reference | |
BCN2848 | Matairesinol 4'-O-beta-gentiobioside |
Matairesinol 4'-O-beta-gentiobioside is a natural product from Trachelospermum jasminoides. | |
BCN5789 | Matairesinol |
Matairesinol has radical and superoxide scavenging activities,; it also has anti-angiogenic activity by suppressing mROS signaling , can decrease hypoxia-inducible factor-1α in hypoxic HeLa cells.Matairesinol has anti-osteoporotic activity via p38/ERK-NFATc1 signaling, but not by way of anti-resorptive action. Matairesinol could markedly benefit TRAIL-based tumor therapies, including those aimed at prostate cancer. |